How Pathology Australia advocates for ‘patient care’ to achieve big corporate profits

Research output: Contribution to Newspaper/Magazine/BulletinArticle

Abstract

We see their spokespeople quoted in the papers and their ads on TV, but beyond that we know very little about how Australia’s lobby groups get what they want. This series shines a light on the strategies, political alignment and policy platforms of eight lobby groups that can influence this election.

Each time we go for a blood test to investigate or keep track of an illness, or have a tissue sample from a Pap test or suspicious mole sent off for analysis, the wheels of the pathology industry are put to work.

Pathology in Australia is big business. One company draws an annual revenue of almost A$4 billion. And a proportion comes from the public purse, via Medicare rebates.
Original languageEnglish
Pages1-3
Number of pages3
Volume2016
No.June
Specialist publicationThe Conversation
PublisherThe Conversation Paperpress
Publication statusPublished - 16 Jun 2016

Fingerprint Dive into the research topics of 'How Pathology Australia advocates for ‘patient care’ to achieve big corporate profits'. Together they form a unique fingerprint.

Cite this